NCT00485901View on ClinicalTrials.gov

Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in Patients With Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

January 31, 2005

Conditions
Schizophrenia
Interventions
DRUG

Olanzapine Hydrochloride

DRUG

Haloperidol

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Taipei

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00485901 - Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in Patients With Schizophrenia | Biotech Hunter | Biotech Hunter